国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (14): 2366-2372.DOI: 10.3760/cma.j.cn441417-20240814101-14016

• 论著 • 上一篇    下一篇

基于SEER分析鼻咽癌患者生存周期及预测模型

李雅琼1 王燕2 袁浩展1 王艳婷1   

  1. 1咸阳市第一人民医院耳鼻咽喉头颈外科,咸阳 712000;2新疆医科大学第一附属医院耳鼻喉科,乌鲁木齐 830013

  • 收稿日期:2024-08-14 出版日期:2025-07-01 发布日期:2025-08-05
  • 通讯作者: 王艳婷,Email:15291103969@163.com
  • 基金资助:

    新疆维吾尔自治区自然科学基金(2020D01C252)

Survival cycle and prediction model of patients with nasopharyngeal carcinoma based on SEER 

Li Yaqiong1, Wang Yan2, Yuan Haozhan1, Wang Yanting1   

  1. 1 Department of Otolaryngology, Head, and Neck Surgery, The First People's Hospital of Xianyang City, Xianyang 712000, China; 2 Department of Otolaryngology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830013, China

  • Received:2024-08-14 Online:2025-07-01 Published:2025-08-05
  • Contact: Wang Yanting, Email: 15291103969@163.com
  • Supported by:

    Natural Science Foundation in Xinjiang Uygur Autonomous Region (2020D01C252)

摘要:

目的 基于监测、流行病学和最终结果数据库(SEER)分析鼻咽癌患者生存周期及预测模型。方法 通过SEER收集2014—2022年鼻咽癌患者1 000例。回顾分析1 000例患者病例资料。利用R 3.6.3软件分析提取的数据;按7∶3的比例将患者分为训练集和验证集,用χ2检验两集合间的可比性,并用训练集建立模型,进行Cox回归分析,在此基础上建立列线图生存预测模型,利用C指数进行训练集和验证集区分度评价及校准曲线进行列线图拟合度检测。结果 1 000例中,男性患者占74.1%(741/1 000),女性患者占25.9%(259/1 000);角化型鳞状细胞癌患者占6.0%(60/1 000),非角化性癌患者占66.1%(661/1 000),基底样鳞状细胞癌患者占5.8%(58/1 000),其他病理类型患者占22.1(221/1 000);未分化占32.4%(324/1 000),低分化占33.0%(330/1 000),中分化占24.4%(244/1 000),高分化占10.2%(102/1 000);鼻咽癌患者总生存率33.9%(339/1 000),病死率66.1%(661/1 000)。为保证后续模型的稳定性,首先用χ2检验分析证实,训练集和验证集患者各项基线特征差异均无统计学意义(均P>0.05);年龄、性别、病理类型、肿瘤分级、TNM分期、转移脏器个数、手术治疗、放射治疗、化学治疗等均对鼻咽癌患者总生存造成影响(均P<0.05),婚姻状况、文化程度、分化程度均未对鼻咽癌患者总生存造成影响(均P>0.05)。对单因素分析结果中P<0.05的因素进行多因素Cox回归分析,结果显示,年龄、性别、病理类型、肿瘤分级、TNM分期、转移脏器个数、手术治疗、放射治疗、化学治疗等均是鼻咽癌患者总生存的独立危险因素,年龄>50岁、女性、非角化型鳞状细胞癌、肿瘤分级高、局部分期晚、器官转移个数多和未接受手术、放疗、化疗的患者预后较差。为更方便直观地应用于临床,综合多因素Cox回归分析结果构建鼻咽癌患者列线图,预测患者3年生存水平,在训练集中,列线图预测模型判断预后的C指数为0.828(95%CI 0.791~0.863),验证集中列线图预测模型判断预后的C指数为0.826(95%CI 0.787~0.862),说明该列线图的RFS预测效果较好。结论 年龄、性别、化疗、TNM分期、病理类型、转移脏器个数是影响鼻咽癌患者生存周期的危险因素。模型构建成功,构建的模型有良好的区分度和拟合度。

关键词: 鼻咽癌, SEER, 生存周期, 预测模型

Abstract:

Objective To analyze the survival cycle and prediction model of patients with nasopharyngeal carcinoma based on the Surveillance Epidemiology and End Results (SEER). Methods A total of 1 000 patients diagnosed with nasopharyngeal carcinoma from 2014 to 2022 were collected through the SEER, and the patients' data were retrospectively analyzed. The extracted data were analyzed using the R 3.6.3 software; the patients were divided into a training set and a verification set according to the ratio of 7∶3. A model was built with the training set, and the Cox regression analysis was performed. On this basis, a nomogram survival prediction model was established. The C-index was used to evaluate the differentiation between the training set and the verification set, and the calibration curve was used to detect the nomogram fit. Results Among the 1 000 patients, 74.1% (741/1 000) were male, and 25.9% (259/1 000) female; the patients with Keratinized squamous cell carcinoma accounted for 6.0% (60/1 000), the patients with non-keratinized squamous cell carcinoma 66.1% (661/1 000), the patients with basal-like squamous cell carcinoma 5.8% (58/1 000), and the patients with other pathological types 22.1% (221/1 000); 32.4% (324/1000) were undifferentiated, 33.0% (330/1 000) poorly differentiated, 24.4% (244/1 000) moderately differentiated, and 10.2% (102/1 000) highly differentiated. The overall survival rate was 33.9% (339/1 000), and the mortality rate was 66.1 (661/1 000). To ensure the stability of the subsequent model, χ2 test was used to confirm that there were no statistical differences in baseline characteristics between the training set and the verification set (all P>0.05). Age, gender, pathological type, tumor grade, TNM stage, number of metastatic organs, surgical treatment, radiotherapy, and chemotherapy all affected the patients' overall survival (all P<0.05), while marital status, education level, and differentiation degree had no effect on the patients' overall survival (all P>0.05). Multivariate Cox regression analysis was performed on the factors with P < 0.05 in the results of univariate analysis. The results showed that age, gender, pathological type, tumor grade, TNM stage, number of metastatic organs, surgical treatment, radiotherapy, and chemotherapy were all independent risk factors for the patients' overall survival. The patients aged > 50 years old, female patients, the patients with non-keratinized squamous cell carcinoma, high tumor grade, late local stage, and more organ metastases, and the patients who did not take surgery, radiotherapy, and chemotherapy had poor prognosis. In order to be more convenient and intuitive for clinical application, a nomogram of the patients was constructed based on the results of multi-factor Cox regression analysis to predict the 3-year survival level. In the training set, the C index of the nomogram prediction model to judge the prognosis was 0.828 (95%CI 0.791-0.863); in the verification set, the C index of the nomogram prediction model to judge the prognosis was 0.826 (95%CI 0.77-0.862); the RFS prediction effect of the nomogram was good. Conclusions Age, gender, chemotherapy, TNM stage, pathological type, and number of metastatic organs are the risk factors affecting the survival cycle of patients with nasopharyngeal carcinoma. The model is successfully constructed, and the model has good differentiation and fit.

Key words: Nasopharyngeal carcinoma,  , SEER,  , Survival cycle,  , Prediction model